Humana (HUM) Price to Earnings (2009 - 2026)

Humana (HUM) has reported Price to Earnings for 18 consecutive years, with 66.8 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 27.68% year-over-year to 66.8 in Q2 2026; TTM through Jun 2026 was 34.77, a 100.64% increase from a year earlier, with the FY2025 full-year figure at 23.67, up 1.15% from the prior year.
• Price to Earnings was 66.8 for Q2 2026 at Humana, up from 17.35 in the prior quarter.
• Over five years, Price to Earnings peaked at 142.23 in Q3 2025 and troughed at 4923.91 in Q4 2022.
• A 5-year average of 235.91 and a median of 53.54 in 2025 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings surged 97.83% in 2023 and slumped 54.61% in 2025, its largest moves.
• Over 5 years, Price to Earnings stood at 4923.91 in 2022, then soared by 97.83% to 107.05 in 2023, then soared by 55.74% to 47.38 in 2024, then advanced by 14.45% to 40.54 in 2025, then soared by 264.8% to 66.8 in 2026.
• The last three Price to Earnings figures came in at 66.8 (Q2 2026), 17.35 (Q1 2026), and 40.54 (Q4 2025), per Business Quant data.